Free Trial

Growth Stocks To Research - May 29th

Novo Nordisk A/S logo with Medical background

Novo Nordisk A/S, Prologis, and Welltower are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to increase revenues and earnings at an above-average rate compared with the overall market. These firms typically reinvest profits into research, development or expansion rather than paying high dividends, leading investors to pay premium valuation multiples in anticipation of strong future growth. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

Shares of NYSE:NVO traded up $0.43 during trading hours on Thursday, hitting $69.03. The stock had a trading volume of 5,208,647 shares, compared to its average volume of 6,725,054. Novo Nordisk A/S has a 1-year low of $57.00 and a 1-year high of $148.15. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.55 and a current ratio of 0.74. The firm has a market capitalization of $309.76 billion, a price-to-earnings ratio of 21.01, a PEG ratio of 0.90 and a beta of 0.65. The stock's fifty day simple moving average is $65.74 and its 200 day simple moving average is $82.29.

Read Our Latest Research Report on NVO

Prologis (PLD)

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.

Prologis stock traded up $1.27 during trading hours on Thursday, hitting $109.19. 2,255,507 shares of the company traded hands, compared to its average volume of 4,183,025. Prologis has a 1-year low of $85.35 and a 1-year high of $132.57. The company has a quick ratio of 0.43, a current ratio of 0.75 and a debt-to-equity ratio of 0.53. The firm has a market cap of $101.32 billion, a P/E ratio of 27.31, a P/E/G ratio of 2.70 and a beta of 1.25. The firm's 50-day simple moving average is $103.97 and its two-hundred day simple moving average is $110.69.

Read Our Latest Research Report on PLD

Welltower (WELL)

Welltower Inc. NYSE: WELL, a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.

Shares of WELL stock traded up $0.50 during mid-day trading on Thursday, hitting $152.20. 1,055,517 shares of the stock traded hands, compared to its average volume of 2,902,558. The company's 50-day simple moving average is $147.73 and its 200-day simple moving average is $141.00. The firm has a market cap of $99.53 billion, a price-to-earnings ratio of 97.59, a price-to-earnings-growth ratio of 2.87 and a beta of 0.94. Welltower has a twelve month low of $99.95 and a twelve month high of $158.55. The company has a debt-to-equity ratio of 0.48, a quick ratio of 4.22 and a current ratio of 4.22.

Read Our Latest Research Report on WELL

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Novo Nordisk A/S Right Now?

Before you consider Novo Nordisk A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novo Nordisk A/S wasn't on the list.

While Novo Nordisk A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines